ERSP

Electronic Retailing Self-Regulation Program

ERSP Refers Advertising for Kelacore to FTC, FDA: Marketer Fails to Respond to ERSP Inquiry

ERSP has announced it will refer direct response advertising for the dietary supplement “Kelacore” to the FTC and FDA after the marketer, Nature's Medicine Associates, failed to respond to an ERSP inquiry.

Read More

ERSP Recommends Theradome Modify, Discontinue Certain Claims for Hair-Loss Laser; Found Advertiser Could Support Certain Claims

ERSP has recommended that Theradome, Inc., modify or discontinue certain advertising claims for Theradome, a product designed to treat hair loss through the use of a low-level laser. ERSP found the marketer could support certain claim

Read More

ERSP Recommends PartnerWithPaul.com, LLC Modify Certain Claims for Affiliate-Marketing Program; Company Agrees to Do So

ERSP has recommended that PartnerWithPaul.com, LLC modify or discontinue certain claims for the company’s Partner With Paul affiliate marketing program.

Read More

ERSP Refers Advertising for Dinamo to FTC, FDA after Marketer Fails to Respond to ERSP Inquiry

ERSP has announced it will refer direct response advertising for Dinamo to the Federal Trade Commission (FTC) and the Food and Drug Administration (FDA) after the marketer, Natures Flava, LLC, failed to respond to an ERSP inquiry.

Read More

ERSP Reviews Advertising for ‘Zvelt,’ Marketer Voluntarily Discontinues Claims

ERSP has recommended Progenum International, LLC modify or discontinue certain claims for Zvelt, a weight-loss patch.

Read More

ERSP Reviews Advertising for ‘Troxyphen,’ Recommends Marketer Modify or Discontinue Certain Claims

The Electronic Retailing Self-Regulation Program (ERSP) has recommended that truDERMA, LLC, discontinue certain claims for the company’s Troxyphen dietary supplement, including claims that the product is “safe and clinically researched.”

Read More